Synopsis: Three small-cap stocks are in focus after collectively securing orders worth nearly Rs 34 crore. Mini Diamonds, Shri Balaji Valve Components, and Quality Power have strengthened their order books through domestic and export wins, improving revenue visibility...
Synopsis: Two stocks are in the spotlight after positive broker views, with significant upside potential of up to 32%. Bernstein has retained its positive view on Nuvama Wealth Management despite short-term negatives, while ICICI Securities has maintained a positive...
Synopsis: UPL shares plunged 13% after announcing a major restructuring and facing a downgrade from Nuvama to ‘Hold’. While the move aims to create a pure-play global crop protection platform, concerns over leverage, potential dilution, valuation, and weak profit...
Synopsis: Generic medicines are cost-effective versions of patented drugs that meet identical safety and efficacy standards. India leads the global generics market due to scale, regulatory compliance, and export strength. Stocks like Sun Pharma, Cipla, Dr Reddy’s,...
Synopsis: Three stocks are set to turn ex-split and ex-bonus next week, drawing investor attention. Stock splits aim to enhance affordability and liquidity, while a bonus issue will expand the share base through accumulated reserves. These corporate actions are...
Synopsis: NSE widened its lead over BSE in February, raising the derivatives market share to 70% while BSE slipped to 30%. With BSE’s ADTO falling 21% versus NSE’s 7% decline, traders shifted toward deeper liquidity and tighter spreads, reinforcing NSE’s dominance...
Synopsis: Shares of Novartis India hit a 20% upper circuit after promoter Novartis AG announced the sale of its 70.68% stake to WaveRise Investments, ChrysCapital Fund X, and Two Infinity Partners. The change in control and expected open offer sparked strong investor...
Synopsis: Hindustan Unilever’s Rs 2,000 crore capacity expansion targets fast-growing premium Beauty & Wellbeing and Home Care segments. With strong financial performance and a premium valuation, the move signals a strategic shift toward high-margin categories,...
Synopsis: Caplin Point Laboratories stands out among mid-sized pharma companies due to its diversified dosage portfolio, strong presence in complex sterile injectables, and strategic expansion into oncology and GLP-1 segments. With specialised manufacturing platforms...
Synopsis: Dr Reddy’s Laboratories has acquired Progynova and Cyclo-Progynova for USD 32.15 million, marking its strategic entry into India’s hormone replacement therapy market. By purchasing established leadership rather than building organically, the company...
